Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Gertner

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Oncoimmunology|November 18, 2016
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemiaAudrey Benyamine, Aude Le Roy, Emilie Mamessier, et al.
Investigative Ophthalmology & Visual Science|October 9, 2015
Inhibition of Noninfectious Uveitis Using Intravenous Administration of Collagen II-Specific Type 1 Regulatory T CellsHélène Asnagli, Marie Jacquin, Nathalie Belmonte, et al.
Current Drug Targets|April 8, 2010
Emerging concepts for the treatment of hematological malignancies with therapeutic monoclonal antibodiesAude-Hélène Capietto, Samarh Keirallah, Emilie Gross, et al.
Blood|March 13, 2009
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodiesJulie Gertner-Dardenne, Cecile Bonnafous, Christine Bezombes, et al.
Journal of Neuroinflammation|October 20, 2024
MOG-specific CAR Tregs: a novel approach to treat multiple sclerosisJihane Frikeche, Marion David, Xavier Mouska, et al.
Journal of Crohn'S & Colitis|September 10, 2024
IL23R-Specific CAR Tregs for the Treatment of Crohn's DiseaseYue Cui, Marion David, Laura Bouchareychas, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Oncoimmunology|November 18, 2016
BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemiaAudrey Benyamine, Aude Le Roy, Emilie Mamessier, et al.
Investigative Ophthalmology & Visual Science|October 9, 2015
Inhibition of Noninfectious Uveitis Using Intravenous Administration of Collagen II-Specific Type 1 Regulatory T CellsHélène Asnagli, Marie Jacquin, Nathalie Belmonte, et al.
Current Drug Targets|April 8, 2010
Emerging concepts for the treatment of hematological malignancies with therapeutic monoclonal antibodiesAude-Hélène Capietto, Samarh Keirallah, Emilie Gross, et al.
Blood|March 13, 2009
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodiesJulie Gertner-Dardenne, Cecile Bonnafous, Christine Bezombes, et al.
Journal of Neuroinflammation|October 20, 2024
MOG-specific CAR Tregs: a novel approach to treat multiple sclerosisJihane Frikeche, Marion David, Xavier Mouska, et al.
Journal of Crohn'S & Colitis|September 10, 2024
IL23R-Specific CAR Tregs for the Treatment of Crohn's DiseaseYue Cui, Marion David, Laura Bouchareychas, et al.
Pageof 2